Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
- PMID: 15349816
- DOI: 10.1387/ijdb.041811af
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
Abstract
Over the last years, the relevance of the matrix metalloproteinase (MMP) family in cancer research has grown considerably. These enzymes were initially associated with the invasive properties of tumour cells, owing to their ability to degrade all major protein components of the extracellular matrix (ECM) and basement membranes. However, further studies have demonstrated the implication of MMPs in early steps of tumour evolution, including stimulation of cell proliferation and modulation of angiogenesis. The establishment of causal relationships between MMP overproduction in tumour or stromal cells and cancer progression has prompted the development of clinical trials with a series of inhibitors designed to block the proteolytic activity of these enzymes. Unfortunately, the results derived from using broad-spectrum MMP inhibitors (MMPIs) for treating patients with advanced cancer have been disappointing in most cases. There are several putative explanations for the lack of success of these MMPIs including the recent finding that some MMPs may play a paradoxical protective role in tumour progression. These observations together with the identification of novel functions for MMPs in early stages of cancer have made necessary a reformulation of MMP inhibition strategies. A better understanding of the functional complexity of this proteolytic system and global approaches to identify the relevant MMPs which must be targeted in each individual cancer patient, will be necessary to clarify whether MMP inhibition may be part of future therapies against cancer.
Similar articles
-
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.Oncogene. 2000 Dec 27;19(56):6642-50. doi: 10.1038/sj.onc.1204097. Oncogene. 2000. PMID: 11426650 Review.
-
The other side of MMPs: protective roles in tumor progression.Cancer Metastasis Rev. 2007 Dec;26(3-4):717-24. doi: 10.1007/s10555-007-9089-4. Cancer Metastasis Rev. 2007. PMID: 17717634 Review.
-
Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4038-47. doi: 10.1158/1078-0432.CCR-04-0125. Clin Cancer Res. 2004. PMID: 15217936
-
Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach.Expert Rev Anticancer Ther. 2005 Feb;5(1):149-63. doi: 10.1586/14737140.5.1.149. Expert Rev Anticancer Ther. 2005. PMID: 15757447 Review.
-
Strategies for MMP inhibition in cancer: innovations for the post-trial era.Nat Rev Cancer. 2002 Sep;2(9):657-72. doi: 10.1038/nrc884. Nat Rev Cancer. 2002. PMID: 12209155 Review.
Cited by
-
Effect of Silymarin on Expression of micro-RNA-21 and Matrix Metalloproteinase (MMP) 2 and 9 and Tissue Inhibitors of Matrix Metalloproteinase (TIMP) 1 and 2 in Hepatocellular Carcinoma Cell Line (HepG2).Med J Islam Repub Iran. 2024 Jul 9;38:78. doi: 10.47176/mjiri.38.78. eCollection 2024. Med J Islam Repub Iran. 2024. PMID: 39416370 Free PMC article.
-
Angiogenesis and Apoptosis: Data Comparison of Similar Microenvironments in the Corpus Luteum and Tumors.Animals (Basel). 2024 Apr 6;14(7):1118. doi: 10.3390/ani14071118. Animals (Basel). 2024. PMID: 38612357 Free PMC article. Review.
-
Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile.Curr Top Med Chem. 2024;24(8):722-736. doi: 10.2174/0115680266290367240130054142. Curr Top Med Chem. 2024. PMID: 38303538 Review.
-
Anti-proliferative effect of Annona extracts on breast cancer cells.Biocell. 2023 Aug 28;47(8):1835-1852. Biocell. 2023. PMID: 37771344 Free PMC article.
-
The Role of Hyperthermia in Potentiation of Anti-Angiogenic Effect of Cisplatin and Resveratrol in Mice Bearing Solid Form of Ehrlich Ascites Tumour.Int J Mol Sci. 2023 Jul 4;24(13):11073. doi: 10.3390/ijms241311073. Int J Mol Sci. 2023. PMID: 37446252 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources